News
Elena Erroba, winner of the Navarra 2021 Management Award organised by AMEDNA-NEEZE
Published: 17th November 2022
Elena Erroba, Director of Business Development, Communication and Marketing at 3P Biopharmaceuticals, has been elected as Navarra’s Businesswoman of the Year 2021
Read more
3P Biopharmaceuticals presents its growth plan at BIOSPAIN to further expand its operations in Europe and the USA
Published: 29th September 2021
The investments will enable the company to increase its mammalian cell-based protein production capacity tenfold and increase its microbial cell-based protein production capacity by 50%. The total floor space of the company will triple.
Read more
3P Biopharmaceuticals appoints Diego Bochoeyer as Director of Strategic Development and Supply Chain
Published: 2nd September 2021
3P Biopharmaceuticals incorporates a new member to the executive management team by engaging Diego Bochoeyer as Director of Strategic Development and Supply Chain.
Read more
3P Biopharmaceuticals enters into alliance with Precirix to develop precision radiopharmaceuticals in oncology
Published: 17th August 2021
3P Biopharmaceuticals and Precirix NV have signed an agreement for the clinical manufacturing of a camelid single-domain antibody fragment (sdAb), the backbone of Precirix’ next product candidate to enter the clinic.
Read more
3P Biopharmaceuticals receives FDA approval
Published: 5th July 2021
The FDA classified 3P facilities as acceptable for the manufacture of the target molecule, and appropriate for its commercialization in the US market, once the product is authorized
Read more
3P Biopharmaceuticals reinforces its commitment to female talent with its participation in the programme ‘Lidera en femenino-STEM’
Published: 29th June 2021
The Head of Quality Assurance & Qualified Person at 3P Biopharmaceuticals, Susana Santesteban, has attended ‘Lidera en femenino-STEM’, a course that aims to help promote the career advancement of STEM women.
Read more
3P Biopharmaceuticals and Buzzard Pharmaceuticals start a cGMP manufacturing collaboration to develop a new treatment to combat solid tumours
Published: 20th June 2021
3P Biopharmaceuticals and Buzzard Pharmaceuticals have entered into a partnership agreement for cGMP manufacturing of the potent IL-1 inhibitor Isunakinra, a recombinant protein for cancer indications.
Read more
Working in biotechnology means working to improve the planet and people’s lives
Published: 27th May 2021
Ion Arocena, CEO of AseBio, has delivered a speech at an event organised as part of the agreement that 3P Biopharmaceuticals has signed with the School of Pharmacy and Nutrition of the University of Navarra to promote training in Biotechnology
Read more
La Universidad y la empresa 3P Biopharmaceuticals potenciarán la investigación y la gestión de talento en tecnología y producción de nuevos medicamentos
Published: 16th March 2021
Han firmado un convenio para favorecer la transformación digital y la formación de profesionales enfocados a la industria farmacéutica
Read more